1. Hemophilia Updates: Incorporating New Concepts Into Practice

4. Introduction

5. SIPPET Study

6. SIPPET Study Results

7. Interpreting the Results

8. MASAC Guidance

9. WFH Guidance

10. Emphasis From the WFH

11. Further Notes on the SIPPET Study

12. Further Notes on the SIPPET Study (cont)

13. Nonreplacement Treatment Approaches

14. Emicizumab

15. Results of the Extended Emicizumab Trial

16. Fitusiran

17. Results of the Phase 1 Fitusiran Trial

18. Further Thoughts on Novel Approaches

19. Overview of EHL Factor Concentrates Available in the United States

20. Clinical Experience With the EHL Factor Products

21. Clinical Experience With the EHL Factor Products (cont)

22. EHL Factor Products: Real-World Data

23. EHL Factor Products: Real-World Data (cont)

24. Gene Therapy

25. Gene Therapy: Preliminary Results

26. Concluding Remarks

27. Abbreviations

28. Abbreviations (cont)